Research and Markets (http://www.researchandmarkets.com/research/s9wmkb/bile_duct_cancer) has announced the addition of the "Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Bile Duct Cancer (Cholangiocarcinoma), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

It also reviews key players involved in the therapeutic development for Bile Duct Cancer (Cholangiocarcinoma) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Bile Duct Cancer (Cholangiocarcinoma) Overview
  3. Therapeutics Development
  4. Pipeline Products for Bile Duct Cancer (Cholangiocarcinoma) - Overview
  5. Pipeline Products for Bile Duct Cancer (Cholangiocarcinoma) - Comparative Analysis
  6. Bile Duct Cancer (Cholangiocarcinoma) - Therapeutics under Development by Companies
  7. Bile Duct Cancer (Cholangiocarcinoma) - Therapeutics under Investigation by Universities/Institutes
  8. Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Bile Duct Cancer (Cholangiocarcinoma) - Products under Development by Companies
  13. Bile Duct Cancer (Cholangiocarcinoma) - Products under Investigation by Universities/Institutes
  14. Bile Duct Cancer (Cholangiocarcinoma) - Companies Involved in Therapeutics Development

Companies Mentioned:

  • 4SC AG
  • Agios Pharmaceuticals, Inc.
  • Ariad Pharmaceuticals, Inc.
  • ArQule, Inc.
  • Array BioPharma Inc.
  • Arrien Pharmaceuticals, LLC
  • Aslan Pharmaceuticals Pte. Ltd.
  • Bayer AG
  • BIND Therapeutics, Inc.
  • Blueprint Medicines
  • Boehringer Ingelheim GmbH
  • Boston Biomedical, Inc.
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • CellAct Pharma GmbH
  • Cellceutix Corporation
  • Concordia Healthcare Corp.
  • Cornerstone Pharmaceuticals, Inc.
  • Delcath Systems, Inc.
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Exelixis, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Komipharm International Co., Ltd.
  • (20+ More)

For more information visit http://www.researchandmarkets.com/research/s9wmkb/bile_duct_cancer